These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 10925964)

  • 21. Non-erosive and erosive gastroesophageal reflux diseases: No difference with regard to reflux pattern and motility abnormalities.
    Martínek J; Benes M; Hucl T; Drastich P; Stirand P; Spicák J
    Scand J Gastroenterol; 2008; 43(7):794-800. PubMed ID: 18584517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acid and bile reflux in erosive reflux disease, non-erosive reflux disease and Barrett's esophagus.
    Hak NG; Mostafa M; Salah T; El-Hemaly M; Haleem M; Abd El-Raouf A; Hamdy E
    Hepatogastroenterology; 2008; 55(82-83):442-7. PubMed ID: 18613384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of esophageal acid exposure distribution along the esophagus among the different gastroesophageal reflux disease (GERD) groups.
    Dickman R; Bautista JM; Wong WM; Bhatt R; Beeler JN; Malagon I; Risner-Adler S; Lam KF; Fass R
    Am J Gastroenterol; 2006 Nov; 101(11):2463-9. PubMed ID: 17090277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Zonulin is not increased in the cardiac and esophageal mucosa of patients with gastroesophageal reflux disease.
    Wex T; Mönkemüller K; Kuester D; Fry L; Kandulski A; Malfertheiner P
    Peptides; 2009 Jun; 30(6):1082-7. PubMed ID: 19463740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antireflux surgery normalizes cyclooxygenase-2 expression in squamous epithelium of the distal esophagus.
    Vallböhmer D; DeMeester SR; Oh DS; Banki F; Kuramochi H; Shimizu D; Hagen JA; Danenberg KD; Danenberg PV; Chandrasoma PT; Peters JH; DeMeester TR
    Am J Gastroenterol; 2006 Jul; 101(7):1458-66. PubMed ID: 16863546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dilated intercellular spaces of esophageal epithelium in nonerosive reflux disease patients with physiological esophageal acid exposure.
    Caviglia R; Ribolsi M; Maggiano N; Gabbrielli AM; Emerenziani S; Guarino MP; Carotti S; Habib FI; Rabitti C; Cicala M
    Am J Gastroenterol; 2005 Mar; 100(3):543-8. PubMed ID: 15743349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of esophageal intraluminal mechanical and chemical stressors on salivary epidermal growth factor in humans.
    Li L; Yu Z; Piascik R; Hetzel DP; Rourk RM; Namiot Z; Sarosiek J; McCallum RW
    Am J Gastroenterol; 1993 Oct; 88(10):1749-55. PubMed ID: 8213719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of upper gastrointestinal tract findings in patients with noncardiac chest pain versus those with gastroesophageal reflux disease (GERD)-related symptoms: results from a national endoscopic database.
    Dickman R; Mattek N; Holub J; Peters D; Fass R
    Am J Gastroenterol; 2007 Jun; 102(6):1173-9. PubMed ID: 17378910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-cardiac chest pain: the long-term natural history and comparison with gastroesophageal reflux disease.
    Williams JF; Sontag SJ; Schnell T; Leya J
    Am J Gastroenterol; 2009 Sep; 104(9):2145-52. PubMed ID: 19513020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased esophageal sensitivity to acid and saline in patients with nonerosive gastro-esophageal reflux disease.
    Nagahara A; Miwa H; Minoo T; Hojo M; Kawabe M; Osada T; Kurosawa A; Asaoka D; Terai T; Ohkusa T; Sato N
    J Clin Gastroenterol; 2006; 40(10):891-5. PubMed ID: 17063106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dilated intercellular spaces in gastroesophageal reflux disease patients and the changes of intercellular spaces after omeprazole treatment.
    Xue Y; Zhou LY; Lin SR
    Chin Med J (Engl); 2008 Jul; 121(14):1297-301. PubMed ID: 18713551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of upper GI endoscopy referral volume on the diagnosis of gastroesophageal reflux disease and its complications: a 1-year cross-sectional study in a referral area with 260,000 inhabitants.
    Mäntynen T; Färkkilä M; Kunnamo I; Mecklin JP; Juhola M; Voutilainen M
    Am J Gastroenterol; 2002 Oct; 97(10):2524-9. PubMed ID: 12385433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pepsin detection in the sputum/saliva for the diagnosis of gastroesophageal reflux disease in patients with clinically suspected atypical gastroesophageal reflux disease symptoms.
    Kim TH; Lee KJ; Yeo M; Kim DK; Cho SW
    Digestion; 2008; 77(3-4):201-6. PubMed ID: 18617742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Non-erosive gastroesophageal reflux disease. Incidence of clinical forms, characteristics of esophageal exposure to acid and symptomatic correlations].
    Soto Pérez JC; Icaza ME; Vargas F; Valdovinos Díaz MA
    Rev Gastroenterol Mex; 2003; 68(2):113-9. PubMed ID: 15127647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Roles of diaphragmatic crural barrier and esophageal body clearance in patients with gastroesophageal reflux disease].
    Sun XH; Ke MY; Wang ZF; Fang XC
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Jun; 24(3):289-93. PubMed ID: 12905637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosis of gastroesophageal reflux disease in elderly subjects using 24-hour esophageal pH monitoring.
    Wu B; Wang M; Li Y
    Chin Med J (Engl); 1999 Apr; 112(4):333-5. PubMed ID: 11593533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hiatal hernia size is the dominant determinant of esophagitis presence and severity in gastroesophageal reflux disease.
    Jones MP; Sloan SS; Rabine JC; Ebert CC; Huang CF; Kahrilas PJ
    Am J Gastroenterol; 2001 Jun; 96(6):1711-7. PubMed ID: 11419819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Barrier function of esophagogastric junction in patients with gastroesophageal reflux disease].
    Ding ZL; Wang ZF; Li HB; Sun XH; Xu L; Ke MY
    Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(34):2382-5. PubMed ID: 17156646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship of severity of gastroesophageal reflux disease with gastric acid secretory profile and esophageal acid exposure during nocturnal acid breakthrough: a study using 24-h dual-channel pH-metry.
    Ghoshal UC; Chourasia D; Tripathi S; Misra A; Singh K
    Scand J Gastroenterol; 2008; 43(6):654-61. PubMed ID: 18569981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased esophageal mucosal/submucosal blood flow in patients with gastroesophageal reflux disease: normalization by treatment with a proton pump inhibitor.
    Mine S; Iida T; Tabata T; Okada Y; Tanaka Y
    J Gastroenterol Hepatol; 2008 Feb; 23(2):303-9. PubMed ID: 17725600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.